Menu
November 15, 2023 : StageZero Life Sciences, Ltd., a leading cancer diagnostics and treatment protocol provider, has announced a significant partnership with My One Medical Source (MOMS), a premier provider of medical testing services. This collaboration will expand access to StageZero’s suite of diagnostics and treatment protocols to MOMS’ extensive network of over 1,000 medical access points (MAPS) across the United States.
Through this partnership, MOMS will integrate StageZero’s innovative diagnostics and treatment protocols into its existing network of healthcare providers. This will enable patients to access StageZero’s advanced cancer detection and treatment options at convenient locations across the country.
StageZero’s suite of diagnostics includes the EarlyCDT Blood Test, a non-invasive blood test that can detect multiple types of cancer early, and the AVRT™ (Advanced Vascular Remodeling Test), a blood test that can identify individuals at high risk of developing cancer. The company’s treatment protocols, such as the COC Protocol, provide personalized treatment plans for cancer patients.
The partnership with MOMS is expected to significantly increase the number of patients accessing StageZero’s life-saving cancer diagnostics and treatment protocols. This collaboration has the potential to make a substantial impact on the fight against cancer by enabling early detection and effective treatment for more patients.
The partnership between StageZero Life Sciences and My One Medical Source is a significant development in the fight against cancer. By expanding access to StageZero’s innovative diagnostics and treatment protocols, this collaboration has the potential to save lives and improve the outcomes for cancer patients.
The increasing availability of advanced cancer detection and treatment options is crucial for reducing cancer mortality rates. StageZero’s non-invasive blood tests and personalized treatment protocols offer promising early detection and effective treatment solutions, respectively.
The partnership with MOMS also highlights the growing trend of collaboration between healthcare providers and technology companies to improve patient care. By leveraging MOMS’ extensive network of medical access points, StageZero can reach a wider patient population and significantly impact the fight against cancer.
The partnership between StageZero Life Sciences and My One Medical Source represents a positive step forward in the fight against cancer. This collaboration will expand access to life-saving cancer diagnostics and treatment protocols, potentially saving lives and improving outcomes for cancer patients.
